Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening
Background: Alzheimer's disease (AD) is the most common cause of dementia in later life. It is manifested by gradual and progressive decline in cognitive function and ability to perform activities of daily living (ADL) and the development of behavioral disturbances. Progressive reduction in function...
Gespeichert in:
| Veröffentlicht in: | Prim Care Companion J Clin Psychiatry |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Physicians Postgraduate Press, Inc.
2000
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181126/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15014648/ https://ncbi.nlm.nih.govhttps://doi.org/10.4088/pcc.v02n0406 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
